Research
Nester released a report titled “Immuno-Oncology
Treatment Market: Global Demand Analysis & Opportunity Outlook 2027” which
delivers detailed overview of the global immuno-oncology treatment market in
terms of market segmentation by product, by administration, by end user and by
region.
Further,
for the in-depth analysis, the report encompasses the industry growth drivers,
restraints, supply and demand risk, market attractiveness, BPS analysis and
Porter’s five force model.
The market
for immune-oncology treatment is projected to grow by a CAGR
of 12.68% during the forecast period, i.e., 2020-2027. Moreover, the market is
anticipated to attain a value of USD 157,230.48 million by the end of the year
2027. Immuno-oncology treatment is a cancer therapy that involves targeting
cancerous cells by stimulating the body’s immune system. The market is
segmented by product, by administration, by end user and by region. On the
basis of administration, the market is bifurcated into standalone therapy and
combination therapy, out of which, the combination therapy segment is estimated
to hold the largest portion in the market as a result of growing number of
approved treatments and higher effectiveness of the therapy.
Based on
region, the market is segmented into North America, Latin America, Europe,
Asia-Pacific and Middle East and Africa, out of which, the largest share is
estimated to be held by the market in North America over the forecast period.
The rising investments by various government and private institutions in the
healthcare industry for the maintenance of high quality healthcare services and
products is anticipated to be the major factor contributing towards the growth
of the market in this region.
Download Sample of This Strategic
Report: https://www.researchnester.com/sample-request-2103
Growing Number Of Cancer Patients In
Hospitals To Support The Market Growth
According
to the World Health Organization, the global cancer burden is estimated to have
risen to 18.1 million new cases and 9.6 million deaths in 2018. The increasing
number of patients in hospitals as compared to other smaller healthcare
settings is anticipated to be a significant growth driving factor for the
immune-oncology market. Moreover, the rising cases of cancer across the globe
is another factor estimated to result in the market growth in the upcoming
years. However, the limited access to healthcare, especially among the cancer
patients residing in low- and middle-income countries, is estimated to become a
growth barrier for the market over the forecast period.
This
report also provides the existing competitive scenario of some of the key
players of the global immuno-oncology
treatment market which includes
company profiling of F. Hoffmann-La Roche Ltd (SWX:
ROG), Merck & Company, Inc. (NYSE: MRK), AstraZeneca Plc. (LON: AZN), Novartis
(SWX: NOVN), Amgen Inc. (NASDAQ: AMGN), Pfizer Inc. (NYSE: PFE), Bristol-Myers
Squibb Company (NYSE: BMY), Eli Lilly and Company (NYSE: LLY), Janssen and
GlaxoSmithKline plc. (LON: GSK).
Request
For Full Report @ https://www.researchnester.com/sample-request-2103
The
profiling enfolds key information of the companies which encompasses business
overview, products and services, key financials and recent news and
developments. On the whole, the report depicts detailed overview of the global immuno-oncology treatment market that will help industry
consultants, equipment manufacturers, existing players searching for expansion
opportunities, new players searching possibilities and other stakeholders to
align their market centric strategies according to the ongoing and expected
trends in the future.
About Research
Nester
Research
Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market
research and consulting with an unbiased and unparalleled approach towards
helping global industrial players, conglomerates and executives for their
future investment while avoiding forthcoming uncertainties. With an
out-of-the-box mindset to produce statistical and analytical market research
reports, we provide strategic consulting so that our clients can make wise
business decisions with clarity while strategizing and planning for their forthcoming
needs and succeed in achieving their future endeavors. We believe every business can expand to its new
horizon, provided a right guidance at a right time is available through
strategic minds.
Contact for more
Info:
AJ
Daniel
Email: sales@researchnester.com
U.S.
Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
%20Security%20Market.jpg)
No comments:
Post a Comment